Cavernous angioma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cavernous angioma}} | {{Cavernous angioma}} | ||
{{CMG}}; {{AE}} [[User:Edzelco|Edzel Lorraine Co, D.M.D., M.D.]] | |||
==Overview== | ==Overview== | ||
[[Surgery]] is the mainstay treatment for cavernous angioma. Complete surgical resection should be done to prevent [[seizures]] and [[hemorrhage]] due to remnant tissue.<br /> | [[Surgery]] is the mainstay [[treatment]] for [[cavernous angioma]]. [[Complete surgical resection]] should be done to prevent [[seizures]] and [[hemorrhage]] due to remnant [[tissue]].<br /> | ||
==Indication== | ==Indication== | ||
* | *[[Progressive neurologic deficit]] | ||
* | *[[Recurrent hemorrhage]] | ||
* | *Intractable [[epilepsy]]<br /> | ||
==Surgery== | ==Surgery== | ||
*[[Surgical resection]] is the most preferred intervention for cavernous angioma. | *[[Surgical resection]] is the most preferred [[intervention]] for [[cavernous angioma]]. | ||
*[[Complete resection]] is needed as remnant tissue can cause high risk of seizure and hemorrhage.<ref name="pmid29535273">{{cite journal| author=Stapleton CJ, Barker FG| title=Cranial Cavernous Malformations: Natural History and Treatment. | journal=Stroke | year= 2018 | volume= 49 | issue= 4 | pages= 1029-1035 | pmid=29535273 | doi=10.1161/STROKEAHA.117.017074 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29535273 }} </ref> | *[[Complete resection]] is needed as remnant [[tissue]] can cause [[high risk]] of [[seizure]] and [[hemorrhage]].<ref name="pmid29535273">{{cite journal| author=Stapleton CJ, Barker FG| title=Cranial Cavernous Malformations: Natural History and Treatment. | journal=Stroke | year= 2018 | volume= 49 | issue= 4 | pages= 1029-1035 | pmid=29535273 | doi=10.1161/STROKEAHA.117.017074 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29535273 }} </ref> | ||
*Factors that complicate procedure include: | *Factors that complicate procedure include: | ||
** | **Presence of [[gliosis]] | ||
**[[ | **[[Calcification]] | ||
** | **[[Hyaline degeneration]] <ref name="pmid12826334">{{cite journal| author=Wang CC, Liu A, Zhang JT, Sun B, Zhao YL| title=Surgical management of brain-stem cavernous malformations: report of 137 cases. | journal=Surg Neurol | year= 2003 | volume= 59 | issue= 6 | pages= 444-54; discussion 454 | pmid=12826334 | doi=10.1016/s0090-3019(03)00187-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12826334 }} </ref> | ||
*If seizure surgery occurs, hemosiderin ring should be removed.<ref name="pmid18754072">{{cite journal| author=Cenzato M, Stefini R, Ambrosi C, Giovanelli M| title=Post-operative remnants of brainstem cavernomas: incidence, risk factors and management. | journal=Acta Neurochir (Wien) | year= 2008 | volume= 150 | issue= 9 | pages= 879-86; discussion 887 | pmid=18754072 | doi=10.1007/s00701-008-0008-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18754072 }} </ref> | *If [[seizure surgery]] occurs, the [[hemosiderin ring]] should be removed.<ref name="pmid18754072">{{cite journal| author=Cenzato M, Stefini R, Ambrosi C, Giovanelli M| title=Post-operative remnants of brainstem cavernomas: incidence, risk factors and management. | journal=Acta Neurochir (Wien) | year= 2008 | volume= 150 | issue= 9 | pages= 879-86; discussion 887 | pmid=18754072 | doi=10.1007/s00701-008-0008-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18754072 }} </ref> | ||
* | * | ||
| Line 30: | Line 28: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category: | [[Category:Up to Date]] | ||
Latest revision as of 13:07, 12 May 2022
|
Cavernous angioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cavernous angioma surgery On the Web |
|
American Roentgen Ray Society Images of Cavernous angioma surgery |
|
Risk calculators and risk factors for Cavernous angioma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Surgery is the mainstay treatment for cavernous angioma. Complete surgical resection should be done to prevent seizures and hemorrhage due to remnant tissue.
Indication
Surgery
- Surgical resection is the most preferred intervention for cavernous angioma.
- Complete resection is needed as remnant tissue can cause high risk of seizure and hemorrhage.[1]
- Factors that complicate procedure include:
- Presence of gliosis
- Calcification
- Hyaline degeneration [2]
- If seizure surgery occurs, the hemosiderin ring should be removed.[3]
References
- ↑ Stapleton CJ, Barker FG (2018). "Cranial Cavernous Malformations: Natural History and Treatment". Stroke. 49 (4): 1029–1035. doi:10.1161/STROKEAHA.117.017074. PMID 29535273.
- ↑ Wang CC, Liu A, Zhang JT, Sun B, Zhao YL (2003). "Surgical management of brain-stem cavernous malformations: report of 137 cases". Surg Neurol. 59 (6): 444–54, discussion 454. doi:10.1016/s0090-3019(03)00187-3. PMID 12826334.
- ↑ Cenzato M, Stefini R, Ambrosi C, Giovanelli M (2008). "Post-operative remnants of brainstem cavernomas: incidence, risk factors and management". Acta Neurochir (Wien). 150 (9): 879–86, discussion 887. doi:10.1007/s00701-008-0008-4. PMID 18754072.